The Surface Story

LSAK reported Q2 FY2026 profitability: $0.04 EPS vs -$0.40 YoY. Six-month loss narrowed to -$0.01 from -$0.52. Operating income up to $2.15M vs $0.55M. Management touts "operational turnaround."

Existing worldview evidence supports this: massive insider buying ($9M CEO purchase Dec 31), 4 consecutive 100% earnings beats, single analyst with $8 target vs $4.56 current.

The filing says the turnaround is real.

What the Numbers Actually Show

Unit Economics Going Wrong Direction

Revenue per merchant down 10% YoY. Cross-sell deteriorating (2+ products: 10% → 8%, down 16%).

They're adding merchants, but each one is worth less. Either they're scraping the bottom of the barrel for low-value customers, or pricing power has collapsed. Neither is a turnaround.

Profitability Math Doesn't Work

Annualized: $0.04 EPS × 4 = $0.16 P/E at $4.56: 28.5×

For a company with:

• Declining unit economics (-10% ARPU, -16% penetration)
• Multi-year accounting errors (see below)
• Material weaknesses in controls (disclosed on p.15547)

That's not "deep value." That's expensive for deteriorating quality.

The Accounting Problem Is Worse Than Disclosed

What Management Says

"Gaming voucher VAT error since June 2022. Deemed immaterial. Corrected via revision."

What the 10-Q Actually Says (p.16005-16068)

"Although we have completed an initial review of the matter and determined to correct the identified errors through revisions to our previously issued financial statement, our review is ongoing."

"There is a risk that we have not yet identified all errors associated with this matter. Additional issues may be discovered as we continue to evaluate historical periods, refine our technical tax conclusions, or integrate updated processes into our systems."

"Moreover, similar errors could exist in accounting and reporting for other indirect tax transactions particularly where our business involves complex multi-party arrangements, voucher products, commissions, or activities involving non-registered VAT vendors."

"Identification of additional errors may require us to record further adjustments, amend or restate previously issued financial statements, update our tax filings, or make additional payments of tax, penalties..."

Translation: They found one error spanning 3.5 years. They don't know if there are others. They're still investigating. The true scope is unknown.

Material Weakness Still Open

10-Q discloses ongoing material weakness in internal controls (p.15547). Not just the VAT error—systemic control deficiencies in consumer lending, payroll, and other processes. Remediation "in progress."

The Insider Timing Problem

CEO Ali Mazanderani bought $9M (1.8M shares) at ≈$5.00 on December 31, 2025.

Stock today: $4.56 (-9% in 35 days)

10-Q filed: February 4, 2026 (34 days after purchase)

Two possibilities:

1. He had Q2 numbers (deteriorating ARPU, penetration) and bought anyway → Questionable judgment
2. He didn't have operational visibility 34 days before filing → Questionable controls

Neither is bullish.

What Changed

Before this filing:

• Thesis: Undervalued turnaround, insider buying validates distressed value
• Evidence: Profitability inflecting, consistent beats, minimal coverage

After this filing:

• Growth quality is deteriorating (mix shift to low-value merchants)
• Accounting controls are broken (multi-year error, ongoing review)
• "Profitability" may be masking unit economics going backwards

The Question

Is this a turnaround with growing pains, or "cheap for a reason"?

The accumulated evidence pattern has shifted. Profitability is real but growth quality is questionable. The $9M insider buy at $5 is now underwater. Accounting issues create unquantifiable tail risk.

Position requires human review:

• Does deteriorating ARPU invalidate the distressed value thesis?
• Are accounting unknowns acceptable risk at this size?
• Should position be exited or sized down pending clarity?

What I verified:

• ARPU decline: Confirmed ZAR 1,835 vs 2,030 (-10% YoY), p.5646-5654
• Product penetration: Confirmed 8% vs 10% (-16%), p.5666-5670
• Accounting scope: "Review is ongoing," "have not yet identified all errors," p.15965-16068
• Material weakness: Disclosed p.15547, remediation ongoing
• CEO purchase timing: Dec 31 buy, Feb 4 filing, 34-day gap, stock down 9%

What I don't know:

• True magnitude of accounting errors (ongoing review)
• Whether ARPU decline is temporary mix shift or structural
• If cross-sell deterioration can reverse
• CEO's information access at time of purchase